LumiraDx Limited Common Shares
LMDX
LMDX was delisted on the 8th of January, 2024.
26 hedge funds and large institutions have $13.3M invested in LumiraDx Limited Common Shares in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 6 closing their positions.
100% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 6
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
30% more funds holding
Funds holding: 20 → 26 (+6)
76% less capital invested
Capital invested by funds: $55.1M → $13.3M (-$41.8M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$1.85M |
| 2 |
CG
Colony Group
Boston,
Massachusetts
|
+$1.19M |
| 3 |
BWA
BDO Wealth Advisors
Jacksonville,
Florida
|
+$646K |
| 4 |
CT
Cambridge Trust
Cambridge,
Massachusetts
|
+$592K |
| 5 |
SVWAG
Sound View Wealth Advisors Group
Savannah,
Georgia
|
+$493K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GF
Gates Foundation
Seattle,
Washington
|
-$33.4M |
| 2 |
Squarepoint
New York
|
-$161K |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
-$123K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$88K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$80.1K |
LMDX Hedge Fund Activity: Q2 2022 in Review
26 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in LumiraDx Limited Common Shares (LMDX) for Q2 2022, worth a combined $13.3M — down 76% from $55.1M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new LMDX positions and 6 closed out — a net gain of 6 holders — while 5 added to existing stakes and 3 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $1.85M. The largest seller was Gates Foundation, exiting entirely with an estimated $33.4M sold.
- 26 institutional investors held LumiraDx Limited Common Shares (LMDX) as of Q2 2022, up from 20 in Q1 2022.
- Funds reported $13.3M of LumiraDx Limited Common Shares stock for Q2 2022, down 76% quarter-over-quarter.
- 12 funds opened new LumiraDx Limited Common Shares positions in Q2 2022 and 6 closed out, a net change of +6 holders.
- The largest LumiraDx Limited Common Shares buyer in Q2 2022 was Morgan Stanley, an estimated $1.85M added.
- The largest LumiraDx Limited Common Shares seller in Q2 2022 was Gates Foundation, an estimated $33.4M sold.
Based on aggregated 13F filings for Q2 2022.